Where does it FIT? the roles of fecal testing and colonoscopy in colorectal cancer screening

Cancer

Volumn 121, Issue 18, 2015, Pages 3186-3189

  Hillyer, Grace Clarke ^a,b   Neugut, Alfred I ^a,b,c  

^a Department of Medicine   (United States)

^b NONE   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FECAL IMMUNOCHEMICAL TESTING; FECES ANALYSIS; GASTROINTESTINAL HEMORRHAGE; GOLD STANDARD; HUMAN; MASS SCREENING; OCCULT BLOOD TEST; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FEMALE; MALE; MORTALITY; PROCEDURES;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING;

EID: 84940964010     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29459     Document Type: Review

References (24)

1. Siegel R, DeSantis C, Jemal A,. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117.
2. Levin B, Lieberman DA, McFarland B, et al., Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-160.
3. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM,; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009; 104: 739-750.
4. Baxter NN, Warren JL, Barrett MJ, Stukel TA, Doria-Rose VP,. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol. 2012; 30: 2664-2669.
5. Nishihara R, Wu K, Lochhead P, et al., Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369: 1095-1105.
6. Patel SG, Ahnen DJ,. Screening for colon polyps and cancer. In:, Miller AB, ed. Epidemiologic Studies in Cancer Prevention and Screening. New York, NY: Springer; 2013: 233-261.
7. Neugut AI, Lebwohl B,. Screening for colorectal cancer: the glass is half full. Am J Public Health. 2009; 99: 592-594.
8. Greegor DH,. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA. 1967; 201: 943-945.
9. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C,. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33: 101-110.
10. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
11. Lee JK, Liles EG, Bent S, Levin TR, Corley DA,. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014; 160: 171-181.
12. U.S. Preventive Services Task Force. Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality; 2008. AHRQ publication 08-05124-EF-3.
13. Levin TR,. Editorial: it's time to make organized colorectal cancer screening convenient and easy for patients. Am J Gastroenterol. 2009; 104: 939-941.
14. Hillyer GC, Schmitt KM, Freedberg DE, et al., Fecal-based colorectal cancer screening among the uninsured in northern Manhattan. Am J Prev Med. 2014; 47: 182-187.
15. Hirabayashi Y, Tanaka S,. Comparison of time trends in colorectal cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. Jpn J Clin Oncol. 2007; 37: 325-327.
16. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-2917.
17. Su SY, Huang JY, Jian ZH, Ho CC, Lung CC, Liaw YP,. Mortality of colorectal cancer in Taiwan, 1971-2010: temporal changes and age-period-cohort analysis. Int J Colorectal Dis. 2012; 27: 1665-1672.
18. Center MM, Jemal A, Smith RA, Ward E,. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59: 366-378.
19. Health Promotion Administration. Taiwan breast cancer, oral cancer, and colorectal cancer screening programs. http://www.hpa.gov.tw/BHPNet/English/ClassShow.aspx?No=201312110001. Accessed January 27, 2015.
20. Chiu HM, Chen SLS, Yen AMF, et al., Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer. 2015; 121: 3221-3229.
21. Wong MC, Ching JY, Chan VC, et al., Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening. Gastrointest Endosc. 2015; 81: 596-607.
22. Hoff G, Dominitz JA,. Contrasting US and European approaches to colorectal cancer screening: which is best? Gut. 2010; 59: 407-414.
23. Stegeman I, de Wijkerslooth TR, Stoop EM, et al., Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut. 2014; 63: 466-471.
24. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al., Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014; 370: 1287-1297.